Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Keith S. Kaye, MD, MPH

Professor of Medicine
Rutgers Robert Wood Johnson Medical School
New Brunswick, NJ, United States

Dr. Kaye is the Chief of the Division of Infectious Diseases and is Professor of Medicine in the Department of Medicine at Robert Wood Johnson Medical School.
He has devoted his career to the prevention and effective management of healthcare-associated infections. In addition to serving in a variety of quality improvement and administrative roles in infection prevention, antimicrobial stewardship, and quality and patient safety, he has served on national and international clinical guidelines committees.
Dr. Kaye’s research interests include the development of antimicrobial resistance (particularly among gram-negative organisms), prevention of healthcare associated infections, management of hospital-acquired infections in the elderly, and innovative approaches to antimicrobial stewardship. He has a long and consistent record of federal funding for research pertaining to management and prevention of multi-drug resistant organisms and healthcare associated infections, including innovative groundbreaking clinical trials.
Dr. Kaye received his medical degree from the University of Pennsylvania and completed his Internal Medicine residency and Infectious Diseases fellowship at Beth Israel Deaconess Medical Center in Boston, MA. During fellowship, Dr. Kaye earned a Masters in Public Health from the Harvard School of Public Health. Dr. Kaye has authored over 350 peer-reviewed articles and 20 book chapters and has frequently presented original research at national and international conferences. Dr. Kaye is a past President of the Society for Health Epidemiology of America (SHEA). He is an internationally recognized expert in healthcare epidemiology and antimicrobial resistance and has been invited to speak on these topics at venues throughout the world.

Disclosure(s): Entasis: Advisor/Consultant (), Honoraria (); GSK: Advisor/Consultant (), Honoraria (); Merck: Advisor/Consultant (), Honoraria (); Shionogi: Advisor/Consultant (), Honoraria (); VenatoRx: Advisor/Consultant (), Honoraria ()

Presentation(s):